Silver Lake Advisory’s Amgen AMGN Stock Holding History

Silver Lake Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-817	Closed	-$267K	–	104
2025 Q4	$267K	Buy	817 +6	+0.7%	+$1.9K	0.1%	97
2025 Q3	$229K	Buy	811 +7	+0.9%	+$2.03K	0.09%	97
2025 Q2	$225K	Buy	804 +6	+0.8%	+$1.7K	0.1%	100
2025 Q1	$249K	Buy	798 +5	+0.6%	+$1.48K	0.11%	92
2024 Q4	$207K	Buy	793 +6	+0.8%	+$1.78K	0.09%	94
2024 Q3	$254K	Buy	787 +5	+0.6%	+$1.64K	0.1%	94
2024 Q2	$244K	Buy	782 +5	+0.6%	+$1.47K	0.11%	89
2024 Q1	$221K	Buy	+777	New	+$227K	0.1%	94

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Silver Lake Advisory's AMGN Position: Q1 2026 in Review

Silver Lake Advisory sold out of Amgen (AMGN) in Q1 2026, closing a stake of 817 shares — an estimated $267K sold.

Silver Lake Advisory first reported a position in AMGN in Q1 2024 and held it in 8 quarters. The position peaked at $267K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Silver Lake Advisory reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Silver Lake Advisory sold 817 Amgen shares in Q1 2026, an estimated $267K.
Silver Lake Advisory first reported a position in Amgen in Q1 2024 and held it in 8 quarters.
Silver Lake Advisory's Amgen position peaked at $267K in Q4 2025.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Silver Lake Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.